Ms. Tzipi Ozer-Armon, CEO of Lumenis, joined the company in May 2012. Before joining Lumenis, Ms. Ozer-Armon headed the Japanese market activities of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), a business with a turnover of more than $800M. Prior to that, Ms. Ozer-Armon served as Senior Vice President of Sales and Marketing at SanDisk (Nasdaq:SNDK), having multi-billion dollars sales’ responsibility; she also served as VP & General Manager of MSystems (Nasdaq: FLSH), and as VP of Corporate Development at Comverse (Nasdaq: CMVT). Ms. Ozer-Armon’s impressive career also includes four years at ATKearney, a Global Management Consulting company based in London, UK. Ms. Ozer-Armon holds a BA magna cum laude in Economics from Tel Aviv University, an MBA majoring in Finance and Marketing, and she is an AMP graduate of the Harvard Business School.
Ms. Ozer-Armon headed the Japanese market activities of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), a business with a turnover of more than $800M. Prior to that, Ms. Ozer-Armon served as Senior Vice President of Sales and Marketing at SanDisk (Nasdaq:SNDK), having multi-billion dollars sales’ responsibility; she also served as VP & General Manager of MSystems (Nasdaq: FLSH), and as VP of Corporate Development at Comverse (Nasdaq: CMVT). Ms. Ozer-Armon’s impressive career also includes four years at ATKearney, a Global Management Consulting company based in London, UK. Ms. Ozer-Armon holds a BA magna cum laude in Economics from Tel Aviv University, an MBA majoring in Finance and Marketing, and she is an AMP graduate of the Harvard Business School.